Dozens of AIDS medications will get cheaper for patients in poor countries under a bulk-purchase deal with generic-drug makers brokered by the Clinton Foundation HIV/AIDS Initiative and the Unitaid consortium, reports Reuters.

New agreements were reached for 41 adult and pediatric treatment regimens, with an average price cut of 16 percent compared with 2008.